Skip to main content

Mineralys Therapeutics, Inc.

MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001933414

In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Mineralys Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
5 insiders, $4.68M in total
Insiders trading
5
Net value
−$4.68M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Mineralys Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Mineralys Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Slingsby Brian TaylorDirector7,805,718IndirectSep 24, 20263
Warren EricChief Commercial Officer38,400Sep 22, 20264
Karydas DaphneDirector6,200Sep 17, 20265
Ferguson James J. IIIChief Medical Officer102,400Aug 12, 20261
Rodman David MalcomChief Medical Officer51,384Aug 12, 202623
Congleton JonChief Executive Officer603,621Jul 15, 20269
RA Capital Healthcare Fund LPDirector5,825,521IndirectMar 31, 20262
Ra Capital Management, L.P.Director5,825,521IndirectMar 31, 20262
Kolchinsky PeterDirector5,825,521IndirectMar 31, 20262
Shah Rajeev M.Director5,825,521IndirectMar 31, 20262
RA Capital Nexus Fund III, L.P.Director5,825,521IndirectMar 31, 20262
Akkaraju SrinivasDirector, 10% Owner6,200Feb 20, 20261
Sblendorio GlennDirector6,200Feb 20, 20261
Levy Adam ScottCFO and Secretary48,538Feb 20, 20264
DiRocco DerekDirector6,200Feb 20, 20261
Gold Alexander MDirector6,200Feb 20, 20262
Catalys Pacific Fund, LP10% Owner7,903,838IndirectNov 21, 20251
Samsara BioCapital, L.P.10% Owner5,674,916IndirectMar 17, 20250
Samsara BioCapital GP, LLC10% Owner5,674,916IndirectMar 17, 20250
Litzka OlivierDirector–May 23, 20240
Takahashi TakeshiDirector–Jul 14, 20230
HBM Healthcare Investments (Cayman) Ltd.10% Owner3,218,106Feb 16, 20230
Asam AlexanderDirector–Feb 13, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 21, 2025 (view filing)6:07 PM ETNov 201 daySlingsby Brian Taylor and 1 otherDirector, 10% OwnerSSale−1.00M$43.35−$43.4M−11.2%7.90M after
Jan 6, 2026 (view filing)Jan 2-54 daysRodman David MalcomChief Medical OfficerSSale−262.8K$35.25−$9.26M−81.0%61.8K after3 lots10b5-1
Jan 13, 2026 (view filing)Jan 121 dayCongleton JonChief Executive OfficerSSale−16.2K$32.62−$529.7K−2.5%639.2K after2 lots10b5-1
Jan 13, 2026 (view filing)Jan 9-124 daysRodman David MalcomChief Medical OfficerSSale−8.52K$32.56−$277.4K−12.1%61.8K after2 lots10b5-1
Jan 13, 2026 (view filing)Jan 121 dayLevy Adam ScottCFO and SecretarySSale−10.8K$32.14−$345.8K−55.5%8.64K after10b5-1
Jan 15, 2026 (view filing)Jan 13-142 daysRodman David MalcomChief Medical OfficerSSale−19.1K$32.67−$623.1K−27.4%50.4K after2 lots10b5-1
Jan 20, 2026 (view filing)Jan 20Same dayRodman David MalcomChief Medical OfficerSSale−416$32.10−$13.4K−0.8%50.4K after10b5-1
Feb 11, 2026 (view filing)Feb 92 daysRodman David MalcomChief Medical OfficerSSale−2.17K$30.21−$65.6K−4.1%50.4K after10b5-1
Feb 13, 2026 (view filing)Feb 12-131 dayRodman David MalcomChief Medical OfficerSSale−20.4K$27.93−$569.8K−31.6%44.1K after5 lots10b5-1
Feb 17, 2026 (view filing)Feb 17Same dayRodman David MalcomChief Medical OfficerSSale−417$27.59−$11.5K−0.9%44.1K after10b5-1
Mar 10, 2026 (view filing)Mar 91 dayRodman David MalcomChief Medical OfficerSSale−2.17K$26.84−$58.3K−2.6%82.5K after10b5-1
Mar 16, 2026 (view filing)Mar 12-134 daysRodman David MalcomChief Medical OfficerSSale−20.4K$26.61−$543.0K−21.1%76.1K after4 lots10b5-1
Mar 17, 2026 (view filing)Mar 17Same dayRodman David MalcomChief Medical OfficerSSale−417$25.65−$10.7K−0.5%76.1K after10b5-1
Mar 31, 2026 (view filing)4:15 PM ETMar 27-304 daysRA Capital Healthcare Fund LP and 4 othersDirectorPPurchase+369.0K$23.75+$8.76M+6.8%5.83M after2 lots
Apr 2, 2026 (view filing)Mar 312 daysCongleton JonChief Executive OfficerSSale−75.0K$26.27−$1.97M−9.6%705.1K after3 lots10b5-1
Apr 2, 2026 (view filing)Mar 312 daysKarydas DaphneDirectorSSale−3.00K$25.00−$75.0K−32.6%6.20K after10b5-1
Apr 13, 2026 (view filing)Apr 94 daysRodman David MalcomChief Medical OfficerSSale−2.17K$27.38−$59.4K−2.8%76.1K after10b5-1
Apr 15, 2026 (view filing)Apr 132 daysCongleton JonChief Executive OfficerSSale−15.7K$26.83−$422.0K−2.2%689.3K after10b5-1
Apr 15, 2026 (view filing)Apr 13-152 daysRodman David MalcomChief Medical OfficerSSale−20.4K$26.89−$548.7K−22.6%69.8K after2 lots10b5-1
Apr 21, 2026 (view filing)Apr 174 daysRodman David MalcomChief Medical OfficerSSale−416$31.33−$13.0K−0.6%69.8K after10b5-1
May 13, 2026 (view filing)May 11-132 daysRodman David MalcomChief Medical OfficerSSale−22.6K$28.91−$652.6K−26.2%63.4K after3 lots10b5-1
May 19, 2026 (view filing)May 181 dayRodman David MalcomChief Medical OfficerSSale−417$27.55−$11.5K−0.7%63.4K after10b5-1
Jun 12, 2026 (view filing)Jun 10-122 daysRodman David MalcomChief Medical OfficerSSale−8.52K$24.20−$206.2K−11.8%63.4K after2 lots10b5-1
Jun 17, 2026 (view filing)Jun 17Same dayKarydas DaphneDirectorSSale−3.00K$25.00−$75.0K−32.6%6.20K after10b5-1
Jun 17, 2026 (view filing)Jun 15-172 daysRodman David MalcomChief Medical OfficerSSale−14.5K$24.19−$350.1K−20.2%57.1K after2 lots10b5-1
Jun 30, 2026 (view filing)Jun 264 daysWarren EricChief Commercial OfficerSSale−104.1K$25.90−$2.70M−73.1%38.4K after10b5-1
Jun 30, 2026 (view filing)Jun 30Same dayCongleton JonChief Executive OfficerSSale−75.0K$26.14−$1.96M−10.9%614.3K after2 lots10b5-1
Jul 10, 2026 (view filing)7:15 PM ETJul 91 dayRodman David MalcomChief Medical OfficerSSale−2.17K$30.30−$65.8K−3.6%57.7K after10b5-1
Jul 15, 2026 (view filing)8:58 PM ETJul 13-152 daysRodman David MalcomChief Medical OfficerSSale−20.4K$27.28−$556.7K−28.4%51.4K after2 lots10b5-1
Jul 15, 2026 (view filing)8:58 PM ETJul 132 daysCongleton JonChief Executive OfficerSSale−10.7K$27.24−$291.4K−1.7%603.6K after10b5-1
Jul 20, 2026 (view filing)9:00 PM ETJul 173 daysRodman David MalcomChief Medical OfficerSSale−416$26.53−$11.0K−0.8%51.4K after10b5-1
Jul 23, 2026 (view filing)6:39 PM ETJul 212 daysWarren EricChief Commercial OfficerSSale−7.44K$26.87−$199.9K−16.2%38.4K after10b5-1
Aug 12, 2026 (view filing)7:33 PM ETAug 102 daysRodman David MalcomChief Medical OfficerSSale−2.17K$27.09−$58.8K−4.1%51.4K after10b5-1
Aug 25, 2026 (view filing)5:16 PM ETAug 214 daysWarren EricChief Commercial OfficerSSale−7.44K$25.98−$193.2K−16.2%38.4K after10b5-1
Sep 17, 2026 (view filing)5:41 PM ETSep 152 daysKarydas DaphneDirectorSSale−3.00K$28.58−$85.7K−32.6%6.20K after10b5-1
Sep 22, 2026 (view filing)6:48 PM ETSep 211 dayWarren EricChief Commercial OfficerSSale−7.44K$28.12−$209.1K−16.2%38.4K after10b5-1
Sep 24, 2026 (view filing)9:49 PM ETSep 222 daysSlingsby Brian TaylorDirectorSSale−104.3K$28.81−$3.01M−1.3%7.81M after